Fight viral infections like COVID-19 with an Immunomodulator.
It has been approved in > 70 countries over last 50 years. Its legal re-classification from POM to OTC category in some countries further reiterates its efficacy & safety
Inosine pranobex acts by strengthening body’s immune response to viral infections, and also inhibits viral replication by slowing down viral mRNA synthesis.